Cellens Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cellens Inc. - overview
Established
2020
Location
-, MA, US
Primary Industry
Healthcare
About
Based in Massachusetts, US, and founded in 2020 by Jonas Pirkl, and XueYing Wang, and Phuong Jean Pham (CEO), Cellens Inc. is a developer of cell fixation, sample processing, nanoimaging cell surface, and machine learning technology platform for bladder cancer detection. In January 2022, the firm raised an amount of seed funding from new investor SOSV. Cellens Inc.
brings clarity and confidence to cancer detection through advanced nanoscale imaging and machine learning. The firm is actively collaborating with cancer clinics, health care professionals, and health insurance organizations.
Current Investors
SOSV
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT
Website
www.cellensinc.com
Verticals
HealthTech, Nanotechnology
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.